Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Caribou Biosciences (CRBU) Revenue (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed Revenue for 6 consecutive years, with $3.9 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 89.74% to $3.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.2 million through Dec 2025, up 11.66% year-over-year, with the annual reading at $11.2 million for FY2025, 11.66% up from the prior year.
  • Revenue for Q4 2025 was $3.9 million at Caribou Biosciences, up from $2.2 million in the prior quarter.
  • The five-year high for Revenue was $23.7 million in Q3 2023, with the low at $1.5 million in Q2 2021.
  • Average Revenue over 5 years is $4.0 million, with a median of $3.0 million recorded in 2022.
  • The sharpest move saw Revenue surged 616.38% in 2023, then crashed 91.45% in 2024.
  • Over 5 years, Revenue stood at $2.6 million in 2021, then surged by 44.28% to $3.7 million in 2022, then fell by 3.63% to $3.6 million in 2023, then tumbled by 41.62% to $2.1 million in 2024, then soared by 89.74% to $3.9 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $3.9 million, $2.2 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.